MedDataX Logo

Efficacy of a Brief Intervention to Improve Sexual and Gender Minorities' Mental Health: Randomized Controlled Trial.

NCT05349877 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2022-04-27

No results posted yet for this study

Summary

Experiences of violence, from micro to physical aggressions, have a deleterious impact on mental health. According to the Minority Stress Theory, unfavorable social conditions (such as anticipated and experienced discrimination and internalized homophobia), mediated by resilience strategies, can lead to mental health or illness. Sexual and gender minorities (SGM) face stigma and discrimination aggravating multiple aspects of their lives: from school drop-out to halting health care access. SGM reveal avoiding medical assistance for fear of discrimination while health professionals disclose feeling unprepared to handle SGM health needs. There are two main challenges: 1) developing specific psychological interventions to reduce the impact of stigma and discrimination on SGM' mental health; and 2) training public health professionals to properly address SGM needs. Therefore, the present trial aims to assess the efficacy of a brief, self-guided, on-line, asynchronous and unsupervised psychological intervention in improving SGM' mental health.

Conditions

  • Depression
  • Anxiety
  • Psychological Distress
  • Social Phobia
  • Post Traumatic Stress Disorder
  • Suicidal Ideation
  • Sex, Unsafe
  • Discrimination, Social
  • Behavior, Risk
  • Self Esteem

Interventions

BEHAVIORAL

Expressive writing

Write, continuously for 20 minutes, about deepest emotions and thoughts concerning experiences of minority stress, exploring a particular event and how it has affected the participant.

BEHAVIORAL

Self-affirmation

Write, continuously for 20 minutes, about values the participant think is important to overcome experiences of minority stress.

BEHAVIORAL

Placebo

Write, continuously for 20 minutes, about their daily routine, without expressing feelings and deep thoughts about it.

Sponsors & Collaborators

  • Pontificia Universidade Católica do Rio Grande do Sul

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-10
Primary Completion
2022-06-30
Completion
2022-12-15

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05349877 on ClinicalTrials.gov